Introduction Mounjaro® (tirzepatide) is FDA-approved for type 2 diabetes management, and you can get it online through telehealth platforms in 2026 with a qualifying…

You do not need a diabetes diagnosis to get a GLP-1 in 2026. Wegovy, Zepbound, and Saxenda are FDA-approved for obesity.

Self-employed adults are in a different position than W-2 employees when it comes to GLP-1 coverage.

You can get a GLP-1 prescription online through telehealth platforms in 2026.

GLP-1 shortages were a defining feature of 2022-2024.

College students have specific complications when it comes to GLP-1 access.

Compounded tirzepatide is available through 503A pharmacies in 2026 when prescribed for an individual patient with documented clinical need.

Compounded semaglutide is legally available through 503A pharmacies in 2026 when prescribed for an individual patient with documented clinical need.

Zepbound came off the FDA shortage list in December 2024, but the higher maintenance doses still hit periodic supply gaps in 2026.